The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-cinnamyl-N-(4-sulfamoylphenyl)piperazine-1-carbothioamide ID: ALA5185515
Cas Number: 664969-54-4
PubChem CID: 1213452
Product Number: L425346, Order Now?
Max Phase: Preclinical
Molecular Formula: C20H24N4O2S2
Molecular Weight: 416.57
Associated Items:
Names and Identifiers Canonical SMILES: NS(=O)(=O)c1ccc(NC(=S)N2CCN(C/C=C/c3ccccc3)CC2)cc1
Standard InChI: InChI=1S/C20H24N4O2S2/c21-28(25,26)19-10-8-18(9-11-19)22-20(27)24-15-13-23(14-16-24)12-4-7-17-5-2-1-3-6-17/h1-11H,12-16H2,(H,22,27)(H2,21,25,26)/b7-4+
Standard InChI Key: ZUQIFHLBPBLRRM-QPJJXVBHSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
2.5014 0.6749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2160 1.0872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9279 0.6753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9279 -0.1498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2178 -0.5616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5014 -0.1535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7868 -0.5661 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0721 -0.1535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3575 -0.5661 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0721 0.6715 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.6424 1.0879 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.3571 0.6753 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0559 1.8038 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2307 1.8038 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.3575 -1.3913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3570 -1.8038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0717 -1.3913 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0717 -0.5661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3570 -0.1535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7863 -1.8038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5009 -1.3913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2155 -1.8038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9302 -1.3913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6449 -1.8037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3571 -1.3917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3571 -0.5663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6468 -0.1543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9302 -0.5626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
6 7 1 0
7 8 1 0
8 9 1 0
8 10 2 0
3 11 1 0
11 12 1 0
11 13 2 0
11 14 2 0
15 9 1 0
16 15 1 0
17 16 1 0
18 17 1 0
19 18 1 0
9 19 1 0
17 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
24 23 2 0
25 24 1 0
26 25 2 0
27 26 1 0
28 27 2 0
23 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 416.57Molecular Weight (Monoisotopic): 416.1341AlogP: 2.36#Rotatable Bonds: 5Polar Surface Area: 78.67Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.31CX Basic pKa: 6.57CX LogP: 3.00CX LogD: 2.94Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.73Np Likeness Score: -1.61
References 1. McCoy MA, Spicer D, Wells N, Hoogewijs K, Fiedler M, Baud MGJ.. (2022) Biophysical Survey of Small-Molecule β-Catenin Inhibitors: A Cautionary Tale., 65 (10.0): [PMID:35581674 ] [10.1021/acs.jmedchem.2c00228 ] 2. Phull MS, Jadav SS, Gundla R, Mainkar PS.. (2021) A perspective on medicinal chemistry approaches towards adenomatous polyposis coli and Wnt signal based colorectal cancer inhibitors., 212 [PMID:33445154 ] [10.1016/j.ejmech.2020.113149 ] 3. Liu Z, Wang P, Wold EA, Song Q, Zhao C, Wang C, Zhou J.. (2021) Small-Molecule Inhibitors Targeting the Canonical WNT Signaling Pathway for the Treatment of Cancer., 64 (8.0): [PMID:33822624 ] [10.1021/acs.jmedchem.0c01799 ]